Treatment Resistant Depression - Pipeline Insight, 2018
SKU ID :DEL-11471684 | Published Date: 01-Jan-2018 | No. of pages: 50Description
TOC
1. Report Introduction
2. Treatment Resistant Depression Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Treatment Resistant Depression
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Tables & Figures
Table 1: Total Products for Treatment Resistant Depression
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products
Figure 1: Total Products for Treatment Resistant Depression
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
Companies
Addex Therapeutics Ltd
Amorsa Therapeutics Inc.
Avanir Pharmaceuticals Inc.
Axsome Therapeutics Inc
Biohaven Pharmaceutical Holding Company Limited
Eli Lilly and Company
Evotec AG
Johnson & Johnson
Otsuka Holdings Co. Ltd.
Relmada Therapeutics Inc.
Reviva Pharmaceuticals Inc.
Sumitomo Dainippon Pharma Co. Ltd.
& list continues...
- PRICE
-
$1250$4000